MMCAP International’s LumiraDx Limited Warrant LMDXW Stock Holding History

MMCAP International’s Portfolio LMDXW Stock Details LMDXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-42,976	Closed	-$314	–	212
2023 Q4	$314	Hold	42,976	–	–	﹤0.01%	191
2023 Q3	$1.25K	Hold	42,976	–	–	﹤0.01%	192
2023 Q2	$1.28K	Hold	42,976	–	–	﹤0.01%	208
2023 Q1	$5.04K	Hold	42,976	–	–	﹤0.01%	249
2022 Q4	$2.54K	Hold	42,976	–	–	﹤0.01%	355
2022 Q3	$5K	Hold	42,976	–	–	﹤0.01%	447
2022 Q2	$41K	Hold	42,976	–	–	﹤0.01%	338
2022 Q1	$38K	Sell	42,976 -4,262	-9%	-$5.48K	﹤0.01%	452
2021 Q4	$85K	Sell	47,238 -27,088	-36%	-$43.7K	0.01%	395
2021 Q3	$86K	Buy	+74,326	New	+$86.2K	0.01%	366

Other funds holding LMDXW

CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

MMCAP International's LMDXW Position: Q1 2024 in Review

MMCAP International sold out of LumiraDx Limited Warrant (LMDXW) in Q1 2024, closing a stake of 42,976 shares — an estimated $314 sold.

MMCAP International first reported a position in LMDXW in Q3 2021 and held it in 10 quarters. The position peaked at $86K in Q3 2021. 4 funds tracked by Wall St. Rank hold LMDXW as of Q1 2024.

MMCAP International reported no remaining LumiraDx Limited Warrant position as of Q1 2024 after selling out during the quarter.
MMCAP International sold 42,976 LumiraDx Limited Warrant shares in Q1 2024, an estimated $314.
MMCAP International first reported a position in LumiraDx Limited Warrant in Q3 2021 and held it in 10 quarters.
MMCAP International's LumiraDx Limited Warrant position peaked at $86K in Q3 2021.
4 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q1 2024.

Based on MMCAP International's 13F filing for Q1 2024, filed 9 May 2024.